Exercise intolerance and systemic manifestations of pulmonary emphysema in a mouse model

Respiratory Research

Volumn 10, Issue , 2009, Pages

  Lüthje, Lars ^a   Raupach, Tobias ^a   Michels, Hellmuth ^a   Unsöld, Bernhard ^a   Hasenfuss, Gerd ^a   Kögler, Harald ^a   Andreas, Stefan ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Lungenfachklinik Immenhausen   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NONOXINOL 9; NORADRENALIN; PANCREATIC ELASTASE; PHOSPHATE BUFFERED SALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIAPHRAGM MOVEMENT; DIAPHRAGM MUSCLE; DISEASE SEVERITY; EXERCISE TOLERANCE; FEMALE; HEART RIGHT VENTRICLE PRESSURE; HISTOLOGY; LUNG EMPHYSEMA; LUNG FUNCTION; MOUSE; MUSCLE FATIGUE; NONHUMAN; NORADRENALIN RELEASE; PULMONARY HYPERTENSION; SYSTEMIC DISEASE; TREADMILL EXERCISE; WEIGHT GAIN; WEIGHT REDUCTION; ADRENERGIC SYSTEM; ANIMAL; CHEMICALLY INDUCED DISORDER; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIAPHRAGM; DISEASE MODEL; HEMODYNAMICS; HOSPITALIZATION; LUNG; LUNG COMPLIANCE; METABOLISM; MUSCLE RELAXATION; PATHOLOGY; PATHOPHYSIOLOGY; SWINE; URINE;

ANIMALS; BODY WEIGHT; DIAPHRAGM; DISEASE MODELS, ANIMAL; EXERCISE TOLERANCE; FEMALE; HEMODYNAMICS; HYPERTENSION, PULMONARY; LUNG; LUNG COMPLIANCE; MICE; MUSCLE FATIGUE; MUSCLE RELAXATION; NOREPINEPHRINE; PANCREATIC ELASTASE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; SEVERITY OF ILLNESS INDEX; SWINE; SYMPATHETIC NERVOUS SYSTEM;

EID: 61549141039     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-10-7     Document Type: Article

References (45)

1. Fabbri LM, Luppi F, Beghe B, Rabe KF. Update in chronic obstructive pulmonary disease 2005. Am J Respir Crit Care Med 2006, 173(10):1056-65. 10.1164/rccm.2603005, 16679444.
2. Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, Gulsvik A, Anderson J, Maden C. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2003, 361(9356):449-56. 10.1016/S0140-6736(03)12459-2, 12583942.
3. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004, 350(10):1005-12. 10.1056/NEJMoa021322, 14999112.
4. Gorman RB, McKenzie DK, Butler JE, Tolman JF, Gandevia SC. Diaphragm length and neural drive after lung volume reduction surgery. Am J Respir Crit Care Med 2005, 172(10):1259-66. 10.1164/rccm.200412-1695OC, 16109977.
5. Pinto-Plata VM, Cote C, Cabral H, Taylor J, Celli BR. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 2004, 23(1):28-33. 10.1183/09031936.03.00034603, 14738227.
6. Fabbri LM, Luppi F, Beghe B, Rabe KF. Complex chronic comorbidities of COPD. Eur Respir J 2008, 31(1):204-12. 10.1183/09031936.00114307, 18166598.
7. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Pare PD. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004, 350(26):2645-53. 10.1056/NEJMoa032158, 15215480.
8. Raupach T, Schafer K, Konstantinides S, Andreas S. Secondhand smoke as an acute threat for the cardiovascular system: a change in paradigm. Eur Heart J 2006, 27(4):386-92. 10.1093/eurheartj/ehi601, 16230308.
9. Reid MB. COPD as a muscle disease. Am J Respir Crit Care Med 2001, 164(7):1101-2.
10. Wright JL, Levy RD, Churg A. Pulmonary hypertension in chronic obstructive pulmonary disease: current theories of pathogenesis and their implications for treatment. Thorax 2005, 60(7):605-9. 1747459, 15994270, 10.1136/thx.2005.042994.
11. Stewart AG, Waterhouse JC, Billings CG, Baylis P, Howard P. Effects of angiotensin converting enzyme inhibition on sodium excretion in patients with hypoxaemic chronic obstructive pulmonary disease. Thorax 1994, 49(10):995-8. 475235, 7974317, 10.1136/thx.49.10.995.
12. Raupach T, Bahr F, Herrmann P, Luethje L, Heusser K, Hasenfuss G, Bernardi L, Andreas S. Slow breathing reduces sympathoexcitation in COPD. Eur Respir J 2008, 32(2):387-92. 10.1183/09031936.00109607, 18385175.
13. Andreas S, Anker SD, Scanlon PD, Somers VK. Neurohumoral activation as a link to systemic manifestations of chronic lung disease. Chest 2005, 128(5):3618-24. 10.1378/chest.128.5.3618, 16304321.
14. Wright JL, Cosio M, Churg A. Animal models of chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol 2008, 295(1):L1-15. 2494776, 18456796, 10.1152/ajplung.90200.2008.
15. Mahadeva R, Shapiro SD. Chronic obstructive pulmonary disease 3: Experimental animal models of pulmonary emphysema. Thorax 2002, 57(10):908-14. 1746206, 12324680, 10.1136/thorax.57.10.908.
16. Dawkins PA, Stockley RA. Animal models of chronic obstructive pulmonary disease. Thorax 2001, 56(12):972-7. 1745992, 11713362, 10.1136/thorax.56.12.972.
17. Foronjy RF, Mirochnitchenko O, Propokenko O, Lemaitre V, Jia Y, Inouye M, Okada Y, D'Armiento JM. Superoxide dismutase expression attenuates cigarette smoke- or elastase-generated emphysema in mice. Am J Respir Crit Care Med 2006, 173(6):623-31. 10.1164/rccm.200506-850OC, 16387805.
18. Snider GL. Experimental studies on emphysema and chronic bronchial injury. Eur J Respir Dis Suppl 1986, 146:17-35.
19. Shapiro SD. Transgenic and gene-targeted mice as models for chronic obstructive pulmonary disease. Eur Respir J 2007, 29(2):375-8. 10.1183/09031936.00087606, 17264324.
20. Heunks LM, Bast A, van Herwaarden CL, Haenen GR, Dekhuijzen PN. Effects of emphysema and training on glutathione oxidation in the hamster diaphragm. J Appl Physiol 2000, 88(6):2054-61.
21. Farkas GA, Roussos C. Histochemical and biochemical correlates of ventilatory muscle fatigue in emphysematous hamsters. J Clin Invest 1984, 74(4):1214-20. 425287, 6237119, 10.1172/JCI111530.
22. Sahebjami H, Vassallo CL. Exercise stress and enzyme-induced emphysema. J Appl Physiol 1976, 41(3):332-5.
23. Mattson JP, Poole DC. Pulmonary emphysema decreases hamster skeletal muscle oxidative enzyme capacity. J Appl Physiol 1998, 85(1):210-4.
24. Gardi C, Cavarra E, Calzoni P, Marcolongo P, de Santi M, Martorana PA, Lungarella G. Neutrophil lysosomal dysfunctions in mutant C57 Bl/6J mice: interstrain variations in content of lysosomal elastase, cathepsin G and their inhibitors. Biochem J 1994, 299(Pt 1):237-45. 1138047, 8166647.
25. Dunnill MS. Evaluation of a Simple Method of Sampling the Lung for Quantitative Histological Analysis. Thorax 1964, 19:443-8. 1018858, 14216974, 10.1136/thx.19.5.443.
26. Yin FC, Spurgeon HA, Rakusan K, Weisfeldt ML, Lakatta EG. Use of tibial length to quantify cardiac hypertrophy: application in the aging rat. Am J Physiol 1982, 243(6):H941-7.
27. Frey N, Frank D, Lippl S, Kuhn C, Kögler H, Barrientos T, Rohr C, Will R, Müller O, Weiler H, Bassel-Duby R, Katus H, Olson E. Deficiency for calsarcin-2 increases exercise capacity in vivo by calcineurin/NFAT activation. J Clin Invest 2008, 2564612, 18846255.
28. Busch RH, Lauhala KE, Loscutoff SM, McDonald KE. Experimental pulmonary emphysema induced in the rat by intratracheally administered elastase: morphogenesis. Environ Res 1984, 33(2):497-513. 10.1016/0013-9351(84)90044-6, 6562016.
29. Ito S, Ingenito EP, Arold SP, Parameswaran H, Tgavalekos NT, Lutchen KR, Suki B. Tissue heterogeneity in the mouse lung: effects of elastase treatment. J Appl Physiol 2004, 97(1):204-12. 10.1152/japplphysiol.01246.2003, 15020580.
30. Herget J, Palecek F, Cermakova M, Vizek M. Pulmonary hypertension in rats with papain emphysema. Respiration 1979, 38(4):204-12. 10.1159/000194082, 523827.
31. Sexton WL, Poole DC. Effects of emphysema on diaphragm blood flow during exercise. J Appl Physiol 1998, 84(3):971-9.
32. Fujita M, Ye Q, Ouchi H, Nakashima N, Hamada N, Hagimoto N, Kuwano K, Mason RJ, Nakanishi Y. Retinoic acid fails to reverse emphysema in adult mouse models. Thorax 2004, 59(3):224-30. 1746974, 14985558, 10.1136/thx.2003.010785.
33. Ishikawa T, Aoshiba K, Yokohori N, Nagai A. Macrophage colony-stimulating factor aggravates rather than regenerates emphysematous lungs in mice. Respiration 2006, 73(4):538-45. 10.1159/000092545, 16601323.
34. Murakami S, Nagaya N, Itoh T, Iwase T, Fujisato T, Nishioka K, Hamada K, Kangawa K, Kimura H. Adrenomedullin regenerates alveoli and vasculature in elastase-induced pulmonary emphysema in mice. Am J Respir Crit Care Med 2005, 172(5):581-9. 10.1164/rccm.200409-1280OC, 15947283.
35. Hantos Z, Adamicza A, Jánosi TZ, Szabari MV, Tolnai J, Suki B. Lung volumes and respiratory mechanics in elastase-induced emphysema in mice. J Appl Physiol 2008, 105(6):1864-72. 10.1152/japplphysiol.90924.2008, 18845778.
36. Shapiro SD. Animal models for COPD. Chest 2000, 117(5 Suppl 1):223S-7S. 10.1378/chest.117.5_suppl_1.223S, 10843920.
37. Lucey EC, Keane J, Kuang PP, Snider GL, Goldstein RH. Severity of elastase-induced emphysema is decreased in tumor necrosis factor-alpha and interleukin-1beta receptor-deficient mice. Lab Invest 2002, 82(1):79-85.
38. Marchand E, De Leyn P, Gayan-Ramirez G, Palecek F, de Bock V, Dom R, Decramer M. Lung volume reduction surgery does not improve diaphragmatic contractile properties or atrophy in hamsters with elastase-induced emphysema. Am J Respir Crit Care Med 2000, 162(3 Pt 1):1052-7.
39. Mattson JP, Delp MD, Poole DC. Differential effects of emphysema on skeletal muscle fibre atrophy in hamsters. Eur Respir J 2004, 23(5):703-7. 10.1183/09031936.04.00104504, 15176683.
40. Creutzberg EC, Schols AM, Bothmer-Quaedvlieg FC, Wouters EF. Prevalence of an elevated resting energy expenditure in patients with chronic obstructive pulmonary disease in relation to body composition and lung function. Eur J Clin Nutr 1998, 52(6):396-401. 10.1038/sj.ejcn.1600571, 9683390.
41. Weitzenblum E. Chronic cor pulmonale. Heart 2003, 89(2):225-30. 1767533, 12527688, 10.1136/heart.89.2.225.
42. Ottenheijm CA, Heunks LM, Dekhuijzen PN. Diaphragm muscle fiber dysfunction in chronic obstructive pulmonary disease: toward a pathophysiological concept. Am J Respir Crit Care Med 2007, 175(12):1233-40. 10.1164/rccm.200701-020PP, 17413128.
43. Man WD, Hopkinson NS, Harraf F, Nikoletou D, Polkey MI, Moxham J. Abdominal muscle and quadriceps strength in chronic obstructive pulmonary disease. Thorax 2005, 60(9):718-22. 1747513, 15923239, 10.1136/thx.2005.040709.
44. Coirault C, Chemla D, Lecarpentier Y. Relaxation of diaphragm muscle. J Appl Physiol 1999, 87(4):1243-52.
45. Morris DG, Sheppard D. Pulmonary emphysema: when more is less. Physiology (Bethesda) 2006, 21:396-403.